Tooman Craig A Insider Trades

Insider Trading History

Track insider trading activity for Tooman Craig A. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Silence Therapeutics Plc
Silence Therapeutics Plc SLN
President And CEO
Holding Value $229k 33,486 shares
Last Trade
Jan 02, 2025 Sale
$36.6M 5,087,839 shares
$7.19
$6.85
Silence Therapeutics Plc
Silence Therapeutics Plc SLN
President And CEO
Holding Value $6.17M 900,000 shares
Last Trade
Jan 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.47M 900,000 shares
$7.19
$6.85
Enzon Pharmaceuticals
Enzon Pharmaceuticals ENZN
Exec VP Finance, CFO
Holding Value $931k 159,200 shares
Last Trade
Jun 18, 2010 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$157M 140,800 shares
$1,113.00
$5.85
Enzon Pharmaceuticals
Enzon Pharmaceuticals ENZN
Exec VP Finance, CFO
Holding Value $1.66M 283,580 shares
Last Trade
Jun 18, 2010 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$157M 140,800 shares
$1,113.00
$5.85
Enzon Pharmaceuticals
Enzon Pharmaceuticals ENZN
Exec VP Finance, CFO
Holding Value $939k 160,480 shares
Last Trade
Jun 18, 2010 Sale (Open Market)Shares sold on the open market or in a private sale.
$137M 123,100 shares
$1,113.00
$5.85
Enzon Pharmaceuticals
Enzon Pharmaceuticals ENZN
Exec VP Finance, CFO
Holding Value $0 0 shares
Last Trade
May 12, 2010 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.54M 6,000 shares
$1,090.00
$5.85
Enzon Pharmaceuticals
Enzon Pharmaceuticals ENZN
Exec VP Finance, CFO
Holding Value $848k 144,906 shares
Last Trade
May 12, 2010 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.54M 6,000 shares
$1,090.00
$5.85
Enzon Pharmaceuticals
Enzon Pharmaceuticals ENZN
Exec VP Finance, CFO
Holding Value $835k 142,780 shares
Last Trade
May 12, 2010 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.32M 2,126 shares
$1,090.00
$5.85
Enzon Pharmaceuticals
Enzon Pharmaceuticals ENZN
Exec. V.p. Finance, CFO
Holding Value $813k 138,906 shares
Last Trade
Apr 03, 2010 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$6.21M 5,930 shares
$1,048.00
$5.85
Enzon Pharmaceuticals
Enzon Pharmaceuticals ENZN
Exec. V.p. Finance, CFO
Holding Value $847k 144,836 shares
Last Trade
Apr 03, 2010 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$17.5M 16,740 shares
$1,048.00
$5.85
Enzon Pharmaceuticals
Enzon Pharmaceuticals ENZN
Exec. V.p. Finance, CFO
Holding Value $131k 22,320 shares
Last Trade
Apr 03, 2010 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$17.5M 16,740 shares
$1,048.00
$5.85
Enzon Pharmaceuticals
Enzon Pharmaceuticals ENZN
Exec. VP Finance, CFO
Holding Value $1.63M 278,096 shares
Last Trade
Feb 24, 2010 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$5.85
Enzon Pharmaceuticals
Enzon Pharmaceuticals ENZN
Exec. VP Finance, CFO
Holding Value $749k 128,096 shares
Last Trade
Feb 24, 2010 Sale (Open Market)Shares sold on the open market or in a private sale.
No data
No data
$5.85
Enzon Pharmaceuticals
Enzon Pharmaceuticals ENZN
Exec. VP Finance, CFO
Holding Value $0 0 shares
Last Trade
Feb 24, 2010 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$5.85
Enzon Pharmaceuticals
Enzon Pharmaceuticals ENZN
Exec VP Finance, CFO
Holding Value $749k 128,096 shares
Last Trade
Jan 27, 2010 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$5.85
Enzon Pharmaceuticals
Enzon Pharmaceuticals ENZN
Exec VP Finance, CFO
Holding Value $723k 123,610 shares
Last Trade
Jan 17, 2010 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
No data
No data
$5.85
Enzon Pharmaceuticals
Enzon Pharmaceuticals ENZN
Exec VP Finance, CFO
Holding Value $668k 114,164 shares
Last Trade
Jan 17, 2010 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
No data
No data
$5.85
Enzon Pharmaceuticals
Enzon Pharmaceuticals ENZN
Exec VP Finance, CFO
Holding Value $747k 127,767 shares
Last Trade
Jan 05, 2010 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$10.8M 10,000 shares
$1,077.00
$5.85
Enzon Pharmaceuticals
Enzon Pharmaceuticals ENZN
Exec VP Finance, CFO
Holding Value $723k 123,610 shares
Last Trade
Jan 05, 2010 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$4.48M 4,157 shares
$1,077.00
$5.85
Enzon Pharmaceuticals
Enzon Pharmaceuticals ENZN
Exec VP Finance, CFO
Holding Value $23.4k 4,000 shares
Last Trade
Nov 23, 2009 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.11M 3,000 shares
$1,037.00
$5.85

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up